Xanadu and University of Alberta Partner to Accelerate Photodynamic Cancer Drug Discovery - Quantum Computing Report

Photonic quantum computing developer Xanadu Quantum Technologies Limited (NASDAQ/TSX: XNDU) has announced a strategic research partnership with the University of Alberta to engineer novel quantum algorithms for oncology and pharmaceutical drug design. Led by Xanadu’s algorithms team and Professor Alex Brown, Chair of the Department of Chemistry at the University of Alberta, the project focuses on modeling complex light-matter interactions in photosensitizers—light-activated chemical compounds utilized in targeted photodynamic cancer therapy (PDT). Photodynamic therapy uses light-activated compounds to selectively destroy localized tumor cells while minimizing systemic damage associated with traditional chemotherapy. However, designing photosensitizer molecules classically presents a severe computational bottleneck: predicting [...]

Raccontata dathequantuminsider.comquantumcomputingreport.com